Article in The EMBO journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Helen ParkDepartment of Pharmacology, Physiology, and Neurosciences, New Jersey Medical School, Rutgers University, Newark, NJ, USA.ORCID http://orcid.org/0009-0000-2445-489X
Iyshwarya BalasubramanianDepartment of Biological Sciences, Rutgers University, Newark, NJ, USA.
Consortium on Intestinal Regeneration and Fetal Reversion: from Atlas to TherapyRC2DK140862 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI SARAH E BLUTT, DARIO BOFFELLI · 2024 to 2026
$6.0M
Transcriptional Mechanisms of Tumor SuppressionR01CA190558 · NCI · RUTGERS, THE STATE UNIV OF N.J. · PI MICHAEL P. VERZI · 2015 to 2026
$3.6M
Paneth cell heterogeneity in infection and inflammationR01DK132885 · NIDDK · RUTGERS THE STATE UNIV OF NJ NEWARK · PI Nan Gao · 2022 to 2026
$2.4M
Mechanism of intestinal TET3-mediated DNA oxidation and transcriptional regulationR01DK139790 · NIDDK · RUTGERS THE STATE UNIV OF NJ NEWARK · PI Jean-Pierre Etchegaray, Nan Gao · 2024 to 2026
$2.1M
Research Supplements to Promote Diversity in Health-Related ResearchR01DK119198 · NIDDK · RUTGERS THE STATE UNIV OF NJ NEWARK · PI GAO, NAN, KIELA, PAWEL R · 2019 to 2023
$1.9M
Mechanisms of Intestinal Epithelial DifferentiationR01DK121915 · NIDDK · RUTGERS, THE STATE UNIV OF N.J. · PI ELLISON, CHRISTOPHER EUGENE, VERZI, MICHAEL P. · 2020 to 2023
$1.7M
Mucosal modulation by LGG and R. gnavus specific tryptophan metabolitesR01AT010243 · NCCIH · RUTGERS THE STATE UNIV OF NJ NEWARK · PI FERRARIS, RONALDO PARAOAN, GAO, NAN · 2018 to 2021
$1.6M
Deep Learning Methods to Integrate Biological Information for Analysis of Single-cell RNAseq DataR15HG012087 · NHGRI · NEW JERSEY INSTITUTE OF TECHNOLOGY · PI WEI, ZHI · 2021 to 2024
$901k
ImageStream X Mark II for NJMS Flow CoreS10OD018103 · OD · RBHS-NEW JERSEY MEDICAL SCHOOL · PI FITZGERALD-BOCARSLY, PATRICIA · 2014 to 2014
$440k
TET-mediated DNA oxidations in mucosal innate defenseR21AI167079 · NIAID · RUTGERS THE STATE UNIV OF NJ NEWARK · PI ETCHEGARAY, JEAN-PIERRE, GAO, NAN · 2022 to 2023
$432k
Salmonella-host interaction is mediated by a novel Cdc42 effector and lipidationsF31DK121428 · NIDDK · RUTGERS THE STATE UNIV OF NJ NEWARK · PI BANDYOPADHYAY, SHEILA · 2019 to 2021
$131k
Crohn's and Colitis Foundation (CCF) 1456013HHS | NIH | National Center for Complementary and Integrative Health (OAM) R01AT010243HHS | NIH | National Human Genome Research Institute (NHGRI) R15HG012087HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R21AI167079HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) F31 DK121428HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) R01DK119198HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) R01DK121915HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) R01DK132885HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) R01DK139790HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) RC2DK140862HHS | NIH | NCI | Division of Cancer Prevention, National Cancer Institute (DCP, NCI) R01CA190558HHS | NIH | NIH Office of the Director (OD) 1S10OD018103National Science Foundation (NSF) IIS 2128307National Science Foundation (NSF) MRI 2117484NCCIH NIH HHS R01 AT010243NCI NIH HHS R01 CA190558NHGRI NIH HHS R15 HG012087NIAID NIH HHS R21 AI167079NIDDK NIH HHS F31 DK121428NIDDK NIH HHS R01 DK119198NIDDK NIH HHS R01 DK121915NIDDK NIH HHS R01 DK132885NIDDK NIH HHS R01 DK139790NIDDK NIH HHS RC2 DK140862NIH HHS S10 OD018103NJ | NJDOH | New Jersey Commission on Brain Injury Research (NJCBIR) COCR24PRF017NJ | NJDOH | New Jersey Commission on Cancer Research (NJCCR) DFHS17PPC036
6 · The paper itself
Abstract
The gut epithelium faces constant environmental oxidative stresses. How it responds to pathological reactive oxygen species (ROS) is not fully understood. Using Paneth cell (PC) lineage reporters and genetic tracing, we show that as PC progenitors mature, a decline in their oxidative phosphorylation (OXPHOS) activity coincides with an increased capacity to produce antimicrobial peptides (AMPs). Direct stimulation by elevated extracellular ROS, often found during gut infection and inflammation, can drive a subset of PCs into mitotic cell division. Increasing mitochondrial superoxide production via impairment or uncoupling of the respiratory electron transport chain similarly stimulated PC cell-cycle entry and dedifferentiation into various intestinal epithelial cell types. Using gain- and loss-of-function approaches, we found that the Rho-GTPase CDC42 in PCs regulates the balance of ROS and antimicrobial peptide production, influencing the outcome of pathogenic infection. CDC42 deficiency impairs mitochondrial respiration in PCs, elevating cellular ROS, plasticity, and inflammation. Together, ROS directly suppress the mature PC phenotypes, contributing to the widely observed PC pathology in inflammatory diseases. Our findings suggest that molecular defects affecting OXPHOS balance and antimicrobial peptide production in PCs will likely impair innate defense and drive inflammatory progression in the intestine.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Reactive oxygen species stimulate Paneth cell plasticity and diminish antimicrobial function. · full record | Socratic